Medinox, Inc.

In Vitro Diagnostics Alliances

Medinox and the Taiwan-based Orient Europharma have agreed to develop and market NOX-100, a new antihypotensive drug. Under the agreement, Orient will acquire the distribution rights to NOX-100 in Tai

Research on stroke is at the same stage as heart attack was twenty years ago, with many drugs just starting to reach the market. In a field notorious for disappointment, companies have to ask themselv